PROVIDER PROFILE · NPI 1871502070

Dinamarie Garcia BaniganMD MPH

PRACTICELAHEY CLINIC HOSPITAL INCSee all providers at this practice →

EndocrinologyBurlington, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

691

Unique beneficiaries

—

Total services

838

Distinct HCPCS

Medicare payment

$47K

Peer benchmark

Total Medicare services vs. 341 Endocrinology providers in MA — above median (cohort median 496).

PRESCRIBING · PART D · 2024

Total Rx claims

3,361

Beneficiaries

—

Total drug cost

$1.1M

Distinct drugs

Brand share

44.5%

Top prescribed drugs

Levothyroxine Sodium533 claims

Testosterone235 claims

Testosterone Cypionate229 claims

Metformin Hcl193 claims

Alendronate Sodium159 claims

QUALITY · MIPS · 2024

Final MIPS score

92.0

Quality

76.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.71%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Dinamarie Garcia Banigan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NORTHEAST HOSPITAL CORPORATION	58	287
CODY, LYNN	33	57
Dmitry Elentuck Diagnostic Radiology · Burlington, MA	16	33
ELIAS, SUSAN	12	38
Lisl Warren Diagnostic Radiology · Burlington, MA	11	22
Paula Kinnunen Internal Medicine · Burlington, MA	11	32

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history